As of 2026-10-24, the Fair Value of Zentalis Pharmaceuticals Inc (ZNTL) is -4.32 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 2.21 USD, the upside of Zentalis Pharmaceuticals Inc is -295.67%.
With the market price of 2.21 USD and our fair value calculation, Zentalis Pharmaceuticals Inc (ZNTL) is not a good investment. Investing in ZNTL stocks now will result in a potential loss of 295.67%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | 5Y Avg | |
| Net income | -158.73 | -236.81 | -292.19 | -165.84 | -137.06 | -198.13 |
| YoY growth | -34.70% | -49.19% | -23.39% | 43.24% | 17.35% | -9.34% |
| Market Cap (mil) | 350.24 |
| P/E | |
| Forward P/E |
| EPS | -0.86 |
| Avg earnings growth rate | -9.34% |
| TTM earnings | -137.06 |